Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > copy of artical pasted from- reddit
View:
Post by health1234 on Nov 26, 2015 8:39pm

copy of artical pasted from- reddit

Obamacare to blame for soaring drug costs: AEI
Americans concerned about not being able to afford life-saving treatments should not blame drug companies for high prices, a former health advisor to George W. Bush said Tuesday.

Dr. Scott Gottlieb of the conservative American Enterprise Institute told CNBC's "Squawk Box" there's not really a drug cost problem in the U.S., except for a small subset of specialty drugs that cost a lot but are providing a lot of benefit.

"What we have is an under-insurance problem," he said. "People are now under-insured, especially for catastrophic drugs if they get a disease like cancer or something like that because of these new [narrow] formulary designs … popularized by the Affordable Care Act."

Read MoreObamacare architect: High-deductible plans overdone

Defined on the government health care website, the term formulary, also known as a drug list, is described as a rundown of treatments covered by a prescription plan or another insurance plan offering prescription drug benefits.

"If the drug is not on your [Obamacare] formulary list, you have no co-insurance. You're completely on your own," said Gottlieb, an advisor to the Centers for Medicare & Medicaid Services in the Bush presidency. The agency, a division of the Health and Human Services Department, administers government health-care programs, including Obamacare. "Since these plans are the predominant structures in Obamacare, they're starting to migrate into commercial plans" in the workplace, he said.

Besides Main Street, outrage over drug pricing has become a hot topic on Wall Street and the presidential campaign trail.

Valeant Pharmaceuticals has been in the crosshairs in recent months in part for its strategy of acquiring drugs and then raising their prices. Turing Pharmaceuticals also drew national attention in September, after acquiring the 62-year-old medicine Daraprim and raising its price by 5,000 percent.

Democratic presidential front-runner Hillary Clinton seized on the Turing example as a springboard for her platform on reducing drug prices

Comment by sunshine7 on Nov 26, 2015 9:57pm
"62-year-old medicine Daraprim and raising its price by 5,000 percent." according to free market theory, this should create an opportunity for the creation and market of a generic version of this drug at a lower cost. In 62 years, this has not happened? Only a matter of time.
Comment by health1234 on Nov 26, 2015 10:18pm
Americans concerned about not being able to afford life-saving treatments should not blame drug companies for high prices. What type of drugs CXR is  involve in- Anybody have some idea ?
Comment by health1234 on Nov 27, 2015 10:45am
What type of drugs are made by CXR and the new company.
Comment by CJAlberta on Nov 27, 2015 11:01am
This post has been removed in accordance with Community Policy
Comment by health1234 on Nov 27, 2015 11:38am
last year after thank giving,volume was 270k, on28 nov From September 2014-September 2015 the average volume has stayed between 250k--300k. Then after September the volume doubled,
Comment by CJAlberta on Nov 27, 2015 11:57am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities